Open Access 01-12-2018 | Research article
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)
Published in: BMC Infectious Diseases | Issue 1/2018
Login to get access